Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGLEC7 | Q9Y286 | 6/20 | 0.59 |
| ▸ | SELP | P16109 | 8/20 | 0.54 |
| ▸ | MAG | P20916 | 5/20 | 0.52 |
| ▸ | SELL | P14151 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29361662 | 1.00 | SIGLEC7 (0.59) | SIGLEC7SELPMAGSELL | |
| SCHEMBL30739464 | 1.00 | SIGLEC7 (0.59) | SIGLEC7SELPMAGSELL | |
| SCHEMBL30173253 | 1.00 | SIGLEC7 (0.59) | SIGLEC7SELPMAGSELL | |
| SCHEMBL29600828 | 1.00 | SIGLEC7 (0.59) | SIGLEC7SELPMAGSELL | |
| SCHEMBL16449748 | 1.00 | SIGLEC7 (0.59) | SIGLEC7SELPMAGSELL | |
| SCHEMBL30651675 | 1.00 | SIGLEC7 (0.59) | SIGLEC7SELPMAGSELL | |
| SCHEMBL30712647 | 1.00 | SIGLEC7 (0.59) | SIGLEC7SELPMAGSELL | |
| SCHEMBL29538893 | 1.00 | SIGLEC7 (0.59) | SIGLEC7SELPMAGSELL | |
| SCHEMBL30650429 | 1.00 | SIGLEC7 (0.59) | SIGLEC7SELPMAGSELL | |
| SCHEMBL30739475 | 1.00 | SIGLEC7 (0.59) | SIGLEC7SELPMAGSELL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240385201-A1 | LIPIDOMIC BIOMARKERS FOR ATHEROSCLEROSIS AND CARDIOVASCULAR DISEASE | ZORA BIOSCIENCES OY (FI) | 2024-11-21 | — | — | US | disclosed |
| US-12025623-B2 | Lipidomic biomarkers for atherosclerosis and cardiovascular disease | ZORA BIOSCIENCES OY (FI) | 2024-07-02 | — | — | US | disclosed |